Stocks-COCP-Cocrystal Pharma Inc

COCP Cocrystal Pharma Inc

1.61 -0.10 (-5.80%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-COCP-Cocrystal Pharma Inc
COCP Cocrystal Pharma Inc
Trade

Overview

Prev Close 1.61
Day's Range 1.59 - 1.64
52 Week Range 1.32 - 3.05
Average Volume (3M) 24.63K
1-Year Return -21.67%
Beta0.7065
Market Cap 17.39M
P/E Ratio-0.97
Revenue0
EPS-1.763
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Sam Lee, PhD; James Joseph Martin, MBA, CPA
Employees
12

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Cocrystal Pharma Inc's revenues decreased by NaN and amounted to 0.00. Net income increased by 53.69% to -17.98M. Net assets decreased by 33.32% to 26.38M and EPS increased from -4.77 to -1.86.
COCP's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-6M-5M-4M-3M-2M-1M0
Gross Margin
N/A
Net Profit Margin
-242.58%
Operating Margin
N/A
Return On Investment
-76.45%
09/23
12/23
03/24
06/24
Total Revenue
0
0
0
0
Gross Profit
-108K
0
-35K
-33K
Operating Income
-6.04M
-5.67M
-4.16M
-5.45M
Net Income
-4.17M
-4.46M
-3.96M
-5.34M